2018
DOI: 10.1007/s40821-018-0107-y
|View full text |Cite
|
Sign up to set email alerts
|

Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…Performance represents a crucial topic for health organizations, as they act in a sector characterized by high consumption of economic resources and a continuous reduction in public funding (Borgonovi and Compagni, 2013;Carletto et al, 2019;Fryer et al, 2009). Moreover, it is essential to guarantee the best possible patient safety, quality of treatments and service provided (Jankuj and Voracek, 2015).…”
Section: Literature Backgroundmentioning
confidence: 99%
“…Performance represents a crucial topic for health organizations, as they act in a sector characterized by high consumption of economic resources and a continuous reduction in public funding (Borgonovi and Compagni, 2013;Carletto et al, 2019;Fryer et al, 2009). Moreover, it is essential to guarantee the best possible patient safety, quality of treatments and service provided (Jankuj and Voracek, 2015).…”
Section: Literature Backgroundmentioning
confidence: 99%